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Abstract
Giant cell angioblastoma is a very rare, local-
ly destructive vascular tumor of intermediate
malignancy without metastatic potential.
There are only a few cases reported in the lit-
erature exclusively in the soft tissue of chil-
dren. For the first time, we report on an adult
patient with a giant cell angioblastoma in the
popliteal fossa. The therapy included tumor
resection with favorable clinical, oncological
and functional outcome. Due to its locally
destructive nature, surgery remains the main-
stay of treatment. Histologically, giant cell
angioblastoma is comprised of nodular aggre-
gates of histiocytoid cells arranged around
bland angiomatous spaces. Because of insuffi-
cient available data in regard to the definition
of the entity, diagnostic criteria and its biolog-
ical potential, it is not included in the new
World Health Organization classification of
tumors of soft tissue and bone. The differential
diagnosis includes plexiform fibrohistiocytic
tumor, myofibroma and giant cell fibroblas-
toma. 
Case Report
A 41-year old patient presented with pain in
the dorsal aspect of his right knee for 4
months. Physical examination revealed pain at
deep flexion and a knee-joint effusion.
Magnetic resonance imaging (MRI) of the
knee showed a solid mass of 1.2¥2.4¥2.1 cm
extent adjacent to the dorsal joint capsule and
the posterior cruciate ligament (PCL) (Figure 1,
T1-weighted image after administration of
gadolinium). Puncture of the knee joint didn’t
reveal any malignant cells, CT-guided core
biopsy contained retrospectively no lesional
tissue and included small fragment of the joint
cartilage leading to the suspicion of a synovial
chondromatosis. The patient ultimately decid-
ed in favor of resection of the painful mass.
Intraoperatively, the tumor mass represented
as a palpable, well-demarcated mass between
the dorsal joint capsule and the PCL. The mass
was R0-resected with preservation of both PCL
and popliteal vessel and a favorable functional
outcome.  
Histologically, the lesion was poorly demar-
cated and vaguely zonated. The first and most
striking feature was the presence of numerous
thick-walled blood vessels (Figures 2A and 3A)
with marked concentric proliferation of bland
spindle cells with smooth muscle actin (SMA)
(1A4 clone, Sigma; 1:20 000) (Inset Figure 2A)
and desmin (not shown) expression. Between
these vessels, there was a diffuse spindle cell
proliferation with a loosely myxoid or collage-
nous matrix and there were focally several
small nodule and linear and plexiform aggre-
gates of histiocytoid cells (Figures 2B and 3B)
containing some multinucleated, CD68 posi-
tive giant cells of osteoclastic type (inset
Figure 2B; clone PG-M1, DAKO; 1:50).
Furthermore there were similar smaller nod-
ules of cells, some of which appeared to be cen-
tered around a vascular lumen, almost giving
the impression that these aggregates are vas-
culocentric. Interestingly, the histiocytoid cells
expressed partially microphtalmia-associated
transcription factor (MITF) (inset Figure 2B;
clone C5+D5; Abcam Limited; 1:50), were
weakly positive for S100 and negative for
CD68, CD34, SMA, desmin. The histopatholog-
ical differential diagnosis included plexiform
fibrohistiocytic tumor. However, the typical
angiomatous character of the lesion (as shown
in Figure 2A and Figure 3A, respectively) didn’t
fit to a plexiform fibrohistiocytic tumor, and
there was not seen the more orderly fascicular
spindle cell component of the plexiform fibro-
histiocytic tumor. So the diagnosis of a giant
cell angioblastoma was revealed. A CT scan of
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Figure 1. T1-weighted magnetic resonance imaging of the right knee after administration
of gadolinium.
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chest and abdomen for staging was completed,
without any signs of metastases or pathologi-
cal lymph nodes. 16 months following the
resection of the lesion there are no clinical and
radiological signs of a local relapse or metas-
tases, and the patient is free of complaints and
is back to his activity level as before surgery. 
Discussion
Giant cell angioblastoma belongs to vascular
tumors of intermediate malignancy, even
though as yet it is not certain that this is pri-
marily an endothelial tumor. It is a very rare
and a locally aggressive disease with no or only
very low metastatic potential.1 It was first
described as a congenital soft-tissue tumor by
Gonzalez-Crussi in 1991.2 Until now, it was not
included in the WHO classification because
the available data are insufficient in regard to
the definition of entity, its diagnostic criteria
and its true biological potential.3
The typical histological findings in giant cell
angioblastoma are thick-walled vascular chan-
nels with an outer proliferation of fibroblastic
spindle cells, nodular aggregates of histiocy-
toid cells and giant cells and a loose mesenchy-
mal stroma. Features typically associated with
malignancy, such as mitoses, cytological atypia
or necrosis are absent in giant cell angioblas-
toma.1 Immunostains show focal positivity for
SMA (smooth muscle actin) in the spindle
cells, suggesting a vascular smooth muscle ori-
gin, whereas CD 68 stains the multinucleated
giant cells.  
These histological features led to the diag-
nosis of a giant cell angioblastoma in our
patient, despite the exceptional patient age
and the atypical location of the lesion in the
popliteal fossa. There has never been
described a giant cell angioblastoma in an
adult and in the popliteal fossa in the literature
before. In the previously reported cases in the
literature the tumor was located in the hand,
forearm, scalp and palate of infants.2,4 Because
of the typical angiomatous character of the
lesion and the lack of the more orderly fascicu-
lar spindle cell component of a plexiform fibro-
histiocytic tumor, it was believed that the his-
tology fits best with a giant cell angioblastoma
and not with a plexiform fibrohistiocytic
tumor, a differential diagnosis in this setting.
Other differential diagnoses include other con-
genital or vascular neoplasms containing giant
cells, such as myofibroma or giant cell fibrob-
lastoma.
Plexiform fibrohistiocytic tumor is a neo-
plasm of children and young adults. The tumor
is characterized by the plexiform and nodular
growth of rounded histiocytoid cells with inter-
spersed osteoclast-like giant cells, but lacks
the angiomatous character or an onion skin-
ning arrangement of giant cell angioblastoma.2
Myofibroma tends to be well demarcated and
usually shows immature round cells in a
hemangiopericytoma-like arrangement with
bundles of mature myofibroblasts with focal
hyalinization. It lacks the plexiform vascular
pattern and multinucleated giant cells.3 Giant
cell fibroblastoma is another pediatric tumor of
multinucleated cells lining pseudovascular
spaces. This tumor expresses CD34, a charac-
teristic that lacks in giant cell angioblastoma
Another differential diagnosis of giant cell
angioblastoma includes an infectious etiology
because of areas similar to granulation tissue
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Figure 2. A) Small and middle sized arteries (arrow) with concentric proliferation of SMA
positive spindle cells (inset; original magnification 200x) in the outer layers are seen
accompanied by myxoid and collagenous connective tissue in the background (hematox-
ilin and eosin staining; original magnification 50x). B) Several small, whorly nodules
(asterisks) consiting of histiocytoid bland cells and containing (arrow) some multinucle-
ated giant cells of osteoclastic type (CD68 positive as seen in the upper inset; original
magnification 200x) are seen in the center of the lesion (hematoxilin and eosin staining;
original magnification 100x). These cells show partial nuclear expression of MITF (lower
inset; original magnification 200x) 
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and granulomas.
The optimal therapy of giant cell angioblas-
toma is not known. Because of the locally infil-
trative character of the lesion, surgery remains
the mainstay of therapy. In the first reported
case of a giant cell angioblastoma by Gonzalez-
Crussi, the upper extremity tumor required an
amputation of the arm.2 Three additional
occurrences of this tumor were also treated by
surgery, but in a different way.4 The palatal
giant cell angioblastoma in a 10-month-old
male could not be completely resected; given
the deforming nature of further excision, no
additional surgery was performed and the
patient was treated with interferon alfa 2b
(IFNα2b) for 4 years. After nearly 5 years no
progression is shown. In a male neonate with
a giant cell angioblastoma involving the right
hypothenar eminence, a surgical cure would
have required amputation of the hand. So, a
therapy with IFNα2b was started, and the
tumor diminished in size over 11 months.
Then, the tumor was subtotally excised and did
not progress after 27 months. Based on these 2
cases, it seems that the antiangiogenic regi-
men of interferon alfa 2b is successful in sup-
pression of the unregulated growth of blood
vessels,5 and that the giant cell angioblastoma
may represent an unusual form of neoplastic
angiogenesis. Another child with a giant cell
angioblastoma on the scalp got also a tumor
resection, follow-up data are unavailable. In
our case of a giant cell angioblastoma in
popliteal fossa, a limb-sparing resection of the
tumor was performed. Imaging controls 12
months later show neither residual tumor nor
local recurrence. Even though it can be diffi-
cult to control the tumor surgically, data about
adjuvant chemotherapy or radiotherapy do not
exist.
Conclusions
In summary clinical features, histological
findings and follow-up data suggest that giant
cell angioblastoma is a non-malignant tumor
with no or only very low metastatic potential,
but the potential of local complications by its
infiltrative character. It isn’t only a rare tumor
during infancy, but can also occur in adults, as
we describe here for the first time.
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                             Case Report
Figure 3. A) There are numerous thick-walled blood vessels (asterisks) with an outer con-
centric proliferation of bland spindle cells. Between these vessels, there is a diffuse spin-
dle cell proliferation with a loosely myxoid or collagenous matrix (hematoxilin and eosin
staining; original magnification 25x). B) Focally there are striking nodular aggregates
(asterisks) of palely eosinophlic histiocytoid cells admixed with occasional osteoclastic
giant cells (arrow) (hematoxilin and eosin staining; original magnification 100x). 
